nodes	percent_of_prediction	percent_of_DWPC	metapath
Mitoxantrone—sarcoma—melanoma	0.381	1	CtDrD
Mitoxantrone—CYP1B1—melanoma	0.175	0.777	CbGaD
Mitoxantrone—ABCC1—Vemurafenib—melanoma	0.0542	0.204	CbGbCtD
Mitoxantrone—ABCB1—melanoma	0.0502	0.223	CbGaD
Mitoxantrone—ABCG2—Vemurafenib—melanoma	0.0362	0.137	CbGbCtD
Mitoxantrone—ABCC1—Dactinomycin—melanoma	0.036	0.136	CbGbCtD
Mitoxantrone—CYP1B1—Docetaxel—melanoma	0.0262	0.0985	CbGbCtD
Mitoxantrone—ABCG2—Dactinomycin—melanoma	0.0241	0.0907	CbGbCtD
Mitoxantrone—CYP2E1—Dacarbazine—melanoma	0.0198	0.0746	CbGbCtD
Mitoxantrone—ABCC1—Docetaxel—melanoma	0.0186	0.07	CbGbCtD
Mitoxantrone—CYP3A4—Temozolomide—melanoma	0.0143	0.0538	CbGbCtD
Mitoxantrone—ABCG2—Docetaxel—melanoma	0.0124	0.0468	CbGbCtD
Mitoxantrone—ABCB1—Dactinomycin—melanoma	0.00869	0.0327	CbGbCtD
Mitoxantrone—CYP3A4—Vemurafenib—melanoma	0.00783	0.0295	CbGbCtD
Mitoxantrone—ABCB1—Docetaxel—melanoma	0.00448	0.0169	CbGbCtD
Mitoxantrone—CYP3A4—Docetaxel—melanoma	0.00269	0.0101	CbGbCtD
Mitoxantrone—PIM1—hair follicle—melanoma	0.00126	0.141	CbGeAlD
Mitoxantrone—TOP2A—Paclitaxel—Docetaxel—melanoma	0.000874	1	CbGdCrCtD
Mitoxantrone—PIM1—eye—melanoma	0.00063	0.0702	CbGeAlD
Mitoxantrone—BTK—mammalian vulva—melanoma	0.000577	0.0643	CbGeAlD
Mitoxantrone—PIM1—skin of body—melanoma	0.000548	0.0611	CbGeAlD
Mitoxantrone—SLC47A2—head—melanoma	0.000548	0.061	CbGeAlD
Mitoxantrone—PIM1—mammalian vulva—melanoma	0.0005	0.0557	CbGeAlD
Mitoxantrone—CYP1B1—hair follicle—melanoma	0.000496	0.0553	CbGeAlD
Mitoxantrone—ABCC1—hair follicle—melanoma	0.000446	0.0497	CbGeAlD
Mitoxantrone—PIM1—head—melanoma	0.000358	0.0399	CbGeAlD
Mitoxantrone—SLC47A1—eye—melanoma	0.000338	0.0376	CbGeAlD
Mitoxantrone—TOP2A—mammalian vulva—melanoma	0.000293	0.0327	CbGeAlD
Mitoxantrone—BTK—lymph node—melanoma	0.000289	0.0322	CbGeAlD
Mitoxantrone—SLC47A1—mammalian vulva—melanoma	0.000268	0.0298	CbGeAlD
Mitoxantrone—PIM1—lymph node—melanoma	0.00025	0.0279	CbGeAlD
Mitoxantrone—CYP1B1—eye—melanoma	0.000247	0.0276	CbGeAlD
Mitoxantrone—CYP1B1—skin of body—melanoma	0.000215	0.024	CbGeAlD
Mitoxantrone—SLC47A1—head—melanoma	0.000192	0.0214	CbGeAlD
Mitoxantrone—ABCC1—mammalian vulva—melanoma	0.000177	0.0197	CbGeAlD
Mitoxantrone—ABCB1—blood vessel—melanoma	0.000171	0.019	CbGeAlD
Mitoxantrone—Neutropenia—Temozolomide—melanoma	0.000161	0.00272	CcSEcCtD
Mitoxantrone—Hyperglycaemia—Carmustine—melanoma	0.000161	0.00272	CcSEcCtD
Mitoxantrone—Upper respiratory tract infection—Temozolomide—melanoma	0.00016	0.00271	CcSEcCtD
Mitoxantrone—Pneumonia—Carmustine—melanoma	0.00016	0.0027	CcSEcCtD
Mitoxantrone—Erectile dysfunction—Temozolomide—melanoma	0.000159	0.00268	CcSEcCtD
Mitoxantrone—Agranulocytosis—Dactinomycin—melanoma	0.000159	0.00268	CcSEcCtD
Mitoxantrone—Sepsis—Docetaxel—melanoma	0.000159	0.00268	CcSEcCtD
Mitoxantrone—Weight increased—Temozolomide—melanoma	0.000157	0.00265	CcSEcCtD
Mitoxantrone—Renal failure—Carmustine—melanoma	0.000157	0.00264	CcSEcCtD
Mitoxantrone—Weight decreased—Temozolomide—melanoma	0.000156	0.00264	CcSEcCtD
Mitoxantrone—Hyperglycaemia—Temozolomide—melanoma	0.000156	0.00263	CcSEcCtD
Mitoxantrone—Stomatitis—Carmustine—melanoma	0.000155	0.00262	CcSEcCtD
Mitoxantrone—Urinary tract infection—Carmustine—melanoma	0.000155	0.00261	CcSEcCtD
Mitoxantrone—Pneumonia—Temozolomide—melanoma	0.000155	0.00261	CcSEcCtD
Mitoxantrone—Phlebitis—Docetaxel—melanoma	0.000154	0.0026	CcSEcCtD
Mitoxantrone—Hepatitis—Dactinomycin—melanoma	0.000153	0.00258	CcSEcCtD
Mitoxantrone—Body temperature increased—Vemurafenib—melanoma	0.000152	0.00256	CcSEcCtD
Mitoxantrone—Pharyngitis—Dactinomycin—melanoma	0.000152	0.00256	CcSEcCtD
Mitoxantrone—Swelling—Docetaxel—melanoma	0.000151	0.00254	CcSEcCtD
Mitoxantrone—Stomatitis—Temozolomide—melanoma	0.00015	0.00253	CcSEcCtD
Mitoxantrone—Urinary tract infection—Temozolomide—melanoma	0.00015	0.00252	CcSEcCtD
Mitoxantrone—Chills—Bleomycin—melanoma	0.000147	0.00248	CcSEcCtD
Mitoxantrone—TOP2A—lymph node—melanoma	0.000147	0.0164	CbGeAlD
Mitoxantrone—Cardiac failure congestive—Docetaxel—melanoma	0.000146	0.00247	CcSEcCtD
Mitoxantrone—ABCG2—mammalian vulva—melanoma	0.000146	0.0163	CbGeAlD
Mitoxantrone—Alopecia—Bleomycin—melanoma	0.000145	0.00244	CcSEcCtD
Mitoxantrone—Sinusitis—Temozolomide—melanoma	0.000144	0.00244	CcSEcCtD
Mitoxantrone—Haemoglobin—Carmustine—melanoma	0.000144	0.00243	CcSEcCtD
Mitoxantrone—Haemorrhage—Carmustine—melanoma	0.000143	0.00241	CcSEcCtD
Mitoxantrone—Erythema—Bleomycin—melanoma	0.000143	0.00241	CcSEcCtD
Mitoxantrone—Hypersensitivity—Vemurafenib—melanoma	0.000142	0.00239	CcSEcCtD
Mitoxantrone—CYP1B1—head—melanoma	0.00014	0.0157	CbGeAlD
Mitoxantrone—Haemoglobin—Temozolomide—melanoma	0.000139	0.00234	CcSEcCtD
Mitoxantrone—Hepatitis—Temozolomide—melanoma	0.000138	0.00233	CcSEcCtD
Mitoxantrone—Haemorrhage—Temozolomide—melanoma	0.000138	0.00233	CcSEcCtD
Mitoxantrone—Asthenia—Vemurafenib—melanoma	0.000138	0.00233	CcSEcCtD
Mitoxantrone—Pharyngitis—Temozolomide—melanoma	0.000137	0.00231	CcSEcCtD
Mitoxantrone—Chills—Dactinomycin—melanoma	0.000137	0.00231	CcSEcCtD
Mitoxantrone—Cardiac failure—Docetaxel—melanoma	0.000136	0.0023	CcSEcCtD
Mitoxantrone—Alopecia—Dactinomycin—melanoma	0.000135	0.00228	CcSEcCtD
Mitoxantrone—SLC47A1—lymph node—melanoma	0.000134	0.015	CbGeAlD
Mitoxantrone—Hyponatraemia—Docetaxel—melanoma	0.000133	0.00225	CcSEcCtD
Mitoxantrone—Erythema—Dactinomycin—melanoma	0.000133	0.00224	CcSEcCtD
Mitoxantrone—Gastrointestinal haemorrhage—Docetaxel—melanoma	0.000133	0.00224	CcSEcCtD
Mitoxantrone—Ill-defined disorder—Bleomycin—melanoma	0.000132	0.00223	CcSEcCtD
Mitoxantrone—Anaemia—Bleomycin—melanoma	0.000132	0.00222	CcSEcCtD
Mitoxantrone—Diarrhoea—Vemurafenib—melanoma	0.000131	0.00222	CcSEcCtD
Mitoxantrone—Malaise—Bleomycin—melanoma	0.000129	0.00217	CcSEcCtD
Mitoxantrone—Arrhythmia—Carmustine—melanoma	0.000128	0.00216	CcSEcCtD
Mitoxantrone—Leukopenia—Bleomycin—melanoma	0.000128	0.00215	CcSEcCtD
Mitoxantrone—Alopecia—Carmustine—melanoma	0.000126	0.00213	CcSEcCtD
Mitoxantrone—Erythema—Carmustine—melanoma	0.000124	0.0021	CcSEcCtD
Mitoxantrone—Cough—Bleomycin—melanoma	0.000124	0.0021	CcSEcCtD
Mitoxantrone—Chills—Temozolomide—melanoma	0.000124	0.00209	CcSEcCtD
Mitoxantrone—Dehydration—Docetaxel—melanoma	0.000124	0.00208	CcSEcCtD
Mitoxantrone—Ill-defined disorder—Dactinomycin—melanoma	0.000123	0.00208	CcSEcCtD
Mitoxantrone—Anaemia—Dactinomycin—melanoma	0.000123	0.00207	CcSEcCtD
Mitoxantrone—Vomiting—Vemurafenib—melanoma	0.000122	0.00206	CcSEcCtD
Mitoxantrone—Alopecia—Temozolomide—melanoma	0.000122	0.00206	CcSEcCtD
Mitoxantrone—Myalgia—Bleomycin—melanoma	0.000121	0.00205	CcSEcCtD
Mitoxantrone—Chest pain—Bleomycin—melanoma	0.000121	0.00205	CcSEcCtD
Mitoxantrone—Abdominal pain upper—Docetaxel—melanoma	0.000121	0.00205	CcSEcCtD
Mitoxantrone—Rash—Vemurafenib—melanoma	0.000121	0.00204	CcSEcCtD
Mitoxantrone—Dermatitis—Vemurafenib—melanoma	0.000121	0.00204	CcSEcCtD
Mitoxantrone—Back pain—Carmustine—melanoma	0.00012	0.00203	CcSEcCtD
Mitoxantrone—Headache—Vemurafenib—melanoma	0.00012	0.00203	CcSEcCtD
Mitoxantrone—Erythema—Temozolomide—melanoma	0.00012	0.00203	CcSEcCtD
Mitoxantrone—Discomfort—Bleomycin—melanoma	0.00012	0.00202	CcSEcCtD
Mitoxantrone—Malaise—Dactinomycin—melanoma	0.00012	0.00202	CcSEcCtD
Mitoxantrone—Aspartate aminotransferase increased—Docetaxel—melanoma	0.00012	0.00202	CcSEcCtD
Mitoxantrone—Leukopenia—Dactinomycin—melanoma	0.000119	0.00201	CcSEcCtD
Mitoxantrone—Dysgeusia—Temozolomide—melanoma	0.000118	0.00199	CcSEcCtD
Mitoxantrone—Confusional state—Bleomycin—melanoma	0.000117	0.00198	CcSEcCtD
Mitoxantrone—Vision blurred—Carmustine—melanoma	0.000117	0.00198	CcSEcCtD
Mitoxantrone—Alanine aminotransferase increased—Docetaxel—melanoma	0.000117	0.00198	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Bleomycin—melanoma	0.000116	0.00196	CcSEcCtD
Mitoxantrone—Oedema—Bleomycin—melanoma	0.000116	0.00196	CcSEcCtD
Mitoxantrone—Back pain—Temozolomide—melanoma	0.000116	0.00196	CcSEcCtD
Mitoxantrone—Infection—Bleomycin—melanoma	0.000116	0.00195	CcSEcCtD
Mitoxantrone—Anaemia—Carmustine—melanoma	0.000115	0.00194	CcSEcCtD
Mitoxantrone—Nausea—Vemurafenib—melanoma	0.000114	0.00193	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Bleomycin—melanoma	0.000114	0.00192	CcSEcCtD
Mitoxantrone—Vision blurred—Temozolomide—melanoma	0.000113	0.00191	CcSEcCtD
Mitoxantrone—Myalgia—Dactinomycin—melanoma	0.000113	0.00191	CcSEcCtD
Mitoxantrone—Discomfort—Dactinomycin—melanoma	0.000112	0.00189	CcSEcCtD
Mitoxantrone—Ill-defined disorder—Temozolomide—melanoma	0.000112	0.00188	CcSEcCtD
Mitoxantrone—Leukopenia—Carmustine—melanoma	0.000111	0.00188	CcSEcCtD
Mitoxantrone—Anaemia—Temozolomide—melanoma	0.000111	0.00188	CcSEcCtD
Mitoxantrone—Anorexia—Bleomycin—melanoma	0.000111	0.00187	CcSEcCtD
Mitoxantrone—Pancytopenia—Docetaxel—melanoma	0.000109	0.00184	CcSEcCtD
Mitoxantrone—Hypotension—Bleomycin—melanoma	0.000109	0.00184	CcSEcCtD
Mitoxantrone—Oedema—Dactinomycin—melanoma	0.000109	0.00183	CcSEcCtD
Mitoxantrone—Malaise—Temozolomide—melanoma	0.000108	0.00183	CcSEcCtD
Mitoxantrone—Convulsion—Carmustine—melanoma	0.000108	0.00182	CcSEcCtD
Mitoxantrone—Infection—Dactinomycin—melanoma	0.000108	0.00182	CcSEcCtD
Mitoxantrone—Leukopenia—Temozolomide—melanoma	0.000108	0.00182	CcSEcCtD
Mitoxantrone—Hypertension—Carmustine—melanoma	0.000107	0.00181	CcSEcCtD
Mitoxantrone—Neutropenia—Docetaxel—melanoma	0.000107	0.00181	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Dactinomycin—melanoma	0.000106	0.00179	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Bleomycin—melanoma	0.000106	0.00179	CcSEcCtD
Mitoxantrone—Chest pain—Carmustine—melanoma	0.000106	0.00179	CcSEcCtD
Mitoxantrone—Myalgia—Carmustine—melanoma	0.000106	0.00179	CcSEcCtD
Mitoxantrone—Anxiety—Carmustine—melanoma	0.000106	0.00178	CcSEcCtD
Mitoxantrone—Cough—Temozolomide—melanoma	0.000105	0.00177	CcSEcCtD
Mitoxantrone—Paraesthesia—Bleomycin—melanoma	0.000105	0.00176	CcSEcCtD
Mitoxantrone—Weight increased—Docetaxel—melanoma	0.000104	0.00176	CcSEcCtD
Mitoxantrone—Convulsion—Temozolomide—melanoma	0.000104	0.00176	CcSEcCtD
Mitoxantrone—Weight decreased—Docetaxel—melanoma	0.000104	0.00175	CcSEcCtD
Mitoxantrone—Hypertension—Temozolomide—melanoma	0.000104	0.00175	CcSEcCtD
Mitoxantrone—Dyspnoea—Bleomycin—melanoma	0.000104	0.00175	CcSEcCtD
Mitoxantrone—Anorexia—Dactinomycin—melanoma	0.000103	0.00175	CcSEcCtD
Mitoxantrone—Pneumonia—Docetaxel—melanoma	0.000103	0.00174	CcSEcCtD
Mitoxantrone—Confusional state—Carmustine—melanoma	0.000102	0.00173	CcSEcCtD
Mitoxantrone—Myalgia—Temozolomide—melanoma	0.000102	0.00173	CcSEcCtD
Mitoxantrone—Arthralgia—Temozolomide—melanoma	0.000102	0.00173	CcSEcCtD
Mitoxantrone—Anxiety—Temozolomide—melanoma	0.000102	0.00172	CcSEcCtD
Mitoxantrone—Oedema—Carmustine—melanoma	0.000102	0.00171	CcSEcCtD
Mitoxantrone—Discomfort—Temozolomide—melanoma	0.000101	0.00171	CcSEcCtD
Mitoxantrone—Decreased appetite—Bleomycin—melanoma	0.000101	0.00171	CcSEcCtD
Mitoxantrone—Infection—Carmustine—melanoma	0.000101	0.0017	CcSEcCtD
Mitoxantrone—Acute coronary syndrome—Docetaxel—melanoma	0.000101	0.0017	CcSEcCtD
Mitoxantrone—Renal failure—Docetaxel—melanoma	0.000101	0.0017	CcSEcCtD
Mitoxantrone—Myocardial infarction—Docetaxel—melanoma	0.0001	0.00169	CcSEcCtD
Mitoxantrone—Jaundice—Docetaxel—melanoma	9.98e-05	0.00168	CcSEcCtD
Mitoxantrone—Stomatitis—Docetaxel—melanoma	9.98e-05	0.00168	CcSEcCtD
Mitoxantrone—Pain—Bleomycin—melanoma	9.95e-05	0.00168	CcSEcCtD
Mitoxantrone—Conjunctivitis—Docetaxel—melanoma	9.95e-05	0.00168	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Carmustine—melanoma	9.95e-05	0.00168	CcSEcCtD
Mitoxantrone—Tachycardia—Carmustine—melanoma	9.92e-05	0.00167	CcSEcCtD
Mitoxantrone—Confusional state—Temozolomide—melanoma	9.9e-05	0.00167	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Dactinomycin—melanoma	9.89e-05	0.00167	CcSEcCtD
Mitoxantrone—CYP1B1—lymph node—melanoma	9.84e-05	0.011	CbGeAlD
Mitoxantrone—Anaphylactic shock—Temozolomide—melanoma	9.82e-05	0.00166	CcSEcCtD
Mitoxantrone—Oedema—Temozolomide—melanoma	9.82e-05	0.00166	CcSEcCtD
Mitoxantrone—Infection—Temozolomide—melanoma	9.75e-05	0.00165	CcSEcCtD
Mitoxantrone—Anorexia—Carmustine—melanoma	9.68e-05	0.00163	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Temozolomide—melanoma	9.61e-05	0.00162	CcSEcCtD
Mitoxantrone—Feeling abnormal—Bleomycin—melanoma	9.59e-05	0.00162	CcSEcCtD
Mitoxantrone—Agranulocytosis—Docetaxel—melanoma	9.55e-05	0.00161	CcSEcCtD
Mitoxantrone—Skin disorder—Temozolomide—melanoma	9.54e-05	0.00161	CcSEcCtD
Mitoxantrone—Hypotension—Carmustine—melanoma	9.49e-05	0.0016	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Temozolomide—melanoma	9.49e-05	0.0016	CcSEcCtD
Mitoxantrone—Decreased appetite—Dactinomycin—melanoma	9.44e-05	0.00159	CcSEcCtD
Mitoxantrone—Fatigue—Dactinomycin—melanoma	9.36e-05	0.00158	CcSEcCtD
Mitoxantrone—Anorexia—Temozolomide—melanoma	9.36e-05	0.00158	CcSEcCtD
Mitoxantrone—Pain—Dactinomycin—melanoma	9.28e-05	0.00157	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Carmustine—melanoma	9.26e-05	0.00156	CcSEcCtD
Mitoxantrone—Urticaria—Bleomycin—melanoma	9.25e-05	0.00156	CcSEcCtD
Mitoxantrone—Haemoglobin—Docetaxel—melanoma	9.24e-05	0.00156	CcSEcCtD
Mitoxantrone—Rhinitis—Docetaxel—melanoma	9.21e-05	0.00155	CcSEcCtD
Mitoxantrone—Body temperature increased—Bleomycin—melanoma	9.2e-05	0.00155	CcSEcCtD
Mitoxantrone—Haemorrhage—Docetaxel—melanoma	9.19e-05	0.00155	CcSEcCtD
Mitoxantrone—Hepatitis—Docetaxel—melanoma	9.19e-05	0.00155	CcSEcCtD
Mitoxantrone—Paraesthesia—Carmustine—melanoma	9.12e-05	0.00154	CcSEcCtD
Mitoxantrone—Pharyngitis—Docetaxel—melanoma	9.12e-05	0.00154	CcSEcCtD
Mitoxantrone—Dyspnoea—Carmustine—melanoma	9.06e-05	0.00153	CcSEcCtD
Mitoxantrone—CYP2E1—head—melanoma	9.06e-05	0.0101	CbGeAlD
Mitoxantrone—Somnolence—Carmustine—melanoma	9.03e-05	0.00152	CcSEcCtD
Mitoxantrone—ABCB1—retina—melanoma	9.01e-05	0.01	CbGeAlD
Mitoxantrone—Feeling abnormal—Dactinomycin—melanoma	8.95e-05	0.00151	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Temozolomide—melanoma	8.95e-05	0.00151	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Dactinomycin—melanoma	8.88e-05	0.0015	CcSEcCtD
Mitoxantrone—ABCC1—lymph node—melanoma	8.85e-05	0.00986	CbGeAlD
Mitoxantrone—Decreased appetite—Carmustine—melanoma	8.83e-05	0.00149	CcSEcCtD
Mitoxantrone—Paraesthesia—Temozolomide—melanoma	8.82e-05	0.00149	CcSEcCtD
Mitoxantrone—Dyspnoea—Temozolomide—melanoma	8.75e-05	0.00148	CcSEcCtD
Mitoxantrone—Somnolence—Temozolomide—melanoma	8.73e-05	0.00147	CcSEcCtD
Mitoxantrone—Constipation—Carmustine—melanoma	8.69e-05	0.00147	CcSEcCtD
Mitoxantrone—Pain—Carmustine—melanoma	8.69e-05	0.00147	CcSEcCtD
Mitoxantrone—Dyspepsia—Temozolomide—melanoma	8.64e-05	0.00146	CcSEcCtD
Mitoxantrone—Abdominal pain—Dactinomycin—melanoma	8.58e-05	0.00145	CcSEcCtD
Mitoxantrone—Body temperature increased—Dactinomycin—melanoma	8.58e-05	0.00145	CcSEcCtD
Mitoxantrone—Hypersensitivity—Bleomycin—melanoma	8.58e-05	0.00145	CcSEcCtD
Mitoxantrone—Decreased appetite—Temozolomide—melanoma	8.54e-05	0.00144	CcSEcCtD
Mitoxantrone—Fatigue—Temozolomide—melanoma	8.46e-05	0.00143	CcSEcCtD
Mitoxantrone—Constipation—Temozolomide—melanoma	8.4e-05	0.00142	CcSEcCtD
Mitoxantrone—Pain—Temozolomide—melanoma	8.4e-05	0.00142	CcSEcCtD
Mitoxantrone—Feeling abnormal—Carmustine—melanoma	8.37e-05	0.00141	CcSEcCtD
Mitoxantrone—Asthenia—Bleomycin—melanoma	8.35e-05	0.00141	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Carmustine—melanoma	8.31e-05	0.0014	CcSEcCtD
Mitoxantrone—Chills—Docetaxel—melanoma	8.25e-05	0.00139	CcSEcCtD
Mitoxantrone—Arrhythmia—Docetaxel—melanoma	8.21e-05	0.00139	CcSEcCtD
Mitoxantrone—Alopecia—Docetaxel—melanoma	8.12e-05	0.00137	CcSEcCtD
Mitoxantrone—Feeling abnormal—Temozolomide—melanoma	8.09e-05	0.00137	CcSEcCtD
Mitoxantrone—Body temperature increased—Carmustine—melanoma	8.03e-05	0.00136	CcSEcCtD
Mitoxantrone—Abdominal pain—Carmustine—melanoma	8.03e-05	0.00136	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Temozolomide—melanoma	8.03e-05	0.00135	CcSEcCtD
Mitoxantrone—Erythema—Docetaxel—melanoma	8e-05	0.00135	CcSEcCtD
Mitoxantrone—Hypersensitivity—Dactinomycin—melanoma	8e-05	0.00135	CcSEcCtD
Mitoxantrone—Dysgeusia—Docetaxel—melanoma	7.83e-05	0.00132	CcSEcCtD
Mitoxantrone—Urticaria—Temozolomide—melanoma	7.8e-05	0.00132	CcSEcCtD
Mitoxantrone—Asthenia—Dactinomycin—melanoma	7.79e-05	0.00131	CcSEcCtD
Mitoxantrone—Body temperature increased—Temozolomide—melanoma	7.76e-05	0.00131	CcSEcCtD
Mitoxantrone—Abdominal pain—Temozolomide—melanoma	7.76e-05	0.00131	CcSEcCtD
Mitoxantrone—Back pain—Docetaxel—melanoma	7.74e-05	0.00131	CcSEcCtD
Mitoxantrone—Hypersensitivity—Carmustine—melanoma	7.49e-05	0.00126	CcSEcCtD
Mitoxantrone—Diarrhoea—Dactinomycin—melanoma	7.43e-05	0.00125	CcSEcCtD
Mitoxantrone—Vomiting—Bleomycin—melanoma	7.4e-05	0.00125	CcSEcCtD
Mitoxantrone—Anaemia—Docetaxel—melanoma	7.39e-05	0.00125	CcSEcCtD
Mitoxantrone—Rash—Bleomycin—melanoma	7.34e-05	0.00124	CcSEcCtD
Mitoxantrone—Dermatitis—Bleomycin—melanoma	7.33e-05	0.00124	CcSEcCtD
Mitoxantrone—ABCG2—lymph node—melanoma	7.32e-05	0.00816	CbGeAlD
Mitoxantrone—Asthenia—Carmustine—melanoma	7.29e-05	0.00123	CcSEcCtD
Mitoxantrone—Hypersensitivity—Temozolomide—melanoma	7.23e-05	0.00122	CcSEcCtD
Mitoxantrone—ABCB1—mammalian vulva—melanoma	7.21e-05	0.00803	CbGeAlD
Mitoxantrone—Leukopenia—Docetaxel—melanoma	7.16e-05	0.00121	CcSEcCtD
Mitoxantrone—Asthenia—Temozolomide—melanoma	7.04e-05	0.00119	CcSEcCtD
Mitoxantrone—Cough—Docetaxel—melanoma	6.98e-05	0.00118	CcSEcCtD
Mitoxantrone—Diarrhoea—Carmustine—melanoma	6.95e-05	0.00117	CcSEcCtD
Mitoxantrone—Convulsion—Docetaxel—melanoma	6.93e-05	0.00117	CcSEcCtD
Mitoxantrone—Nausea—Bleomycin—melanoma	6.91e-05	0.00117	CcSEcCtD
Mitoxantrone—Hypertension—Docetaxel—melanoma	6.91e-05	0.00117	CcSEcCtD
Mitoxantrone—Vomiting—Dactinomycin—melanoma	6.9e-05	0.00116	CcSEcCtD
Mitoxantrone—Rash—Dactinomycin—melanoma	6.84e-05	0.00115	CcSEcCtD
Mitoxantrone—Arthralgia—Docetaxel—melanoma	6.81e-05	0.00115	CcSEcCtD
Mitoxantrone—Myalgia—Docetaxel—melanoma	6.81e-05	0.00115	CcSEcCtD
Mitoxantrone—Chest pain—Docetaxel—melanoma	6.81e-05	0.00115	CcSEcCtD
Mitoxantrone—Diarrhoea—Temozolomide—melanoma	6.72e-05	0.00113	CcSEcCtD
Mitoxantrone—Confusional state—Docetaxel—melanoma	6.58e-05	0.00111	CcSEcCtD
Mitoxantrone—Oedema—Docetaxel—melanoma	6.53e-05	0.0011	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Docetaxel—melanoma	6.53e-05	0.0011	CcSEcCtD
Mitoxantrone—Infection—Docetaxel—melanoma	6.49e-05	0.00109	CcSEcCtD
Mitoxantrone—Vomiting—Carmustine—melanoma	6.46e-05	0.00109	CcSEcCtD
Mitoxantrone—Nausea—Dactinomycin—melanoma	6.45e-05	0.00109	CcSEcCtD
Mitoxantrone—Shock—Docetaxel—melanoma	6.42e-05	0.00108	CcSEcCtD
Mitoxantrone—Rash—Carmustine—melanoma	6.41e-05	0.00108	CcSEcCtD
Mitoxantrone—Dermatitis—Carmustine—melanoma	6.4e-05	0.00108	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Docetaxel—melanoma	6.39e-05	0.00108	CcSEcCtD
Mitoxantrone—Tachycardia—Docetaxel—melanoma	6.37e-05	0.00108	CcSEcCtD
Mitoxantrone—Headache—Carmustine—melanoma	6.36e-05	0.00107	CcSEcCtD
Mitoxantrone—Skin disorder—Docetaxel—melanoma	6.34e-05	0.00107	CcSEcCtD
Mitoxantrone—Vomiting—Temozolomide—melanoma	6.24e-05	0.00105	CcSEcCtD
Mitoxantrone—Anorexia—Docetaxel—melanoma	6.22e-05	0.00105	CcSEcCtD
Mitoxantrone—Rash—Temozolomide—melanoma	6.19e-05	0.00104	CcSEcCtD
Mitoxantrone—Dermatitis—Temozolomide—melanoma	6.18e-05	0.00104	CcSEcCtD
Mitoxantrone—Headache—Temozolomide—melanoma	6.15e-05	0.00104	CcSEcCtD
Mitoxantrone—Hypotension—Docetaxel—melanoma	6.1e-05	0.00103	CcSEcCtD
Mitoxantrone—Nausea—Carmustine—melanoma	6.03e-05	0.00102	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Docetaxel—melanoma	5.95e-05	0.001	CcSEcCtD
Mitoxantrone—Paraesthesia—Docetaxel—melanoma	5.86e-05	0.000989	CcSEcCtD
Mitoxantrone—Nausea—Temozolomide—melanoma	5.83e-05	0.000984	CcSEcCtD
Mitoxantrone—Dyspnoea—Docetaxel—melanoma	5.82e-05	0.000982	CcSEcCtD
Mitoxantrone—Somnolence—Docetaxel—melanoma	5.8e-05	0.000979	CcSEcCtD
Mitoxantrone—Dyspepsia—Docetaxel—melanoma	5.75e-05	0.00097	CcSEcCtD
Mitoxantrone—Decreased appetite—Docetaxel—melanoma	5.68e-05	0.000958	CcSEcCtD
Mitoxantrone—Fatigue—Docetaxel—melanoma	5.63e-05	0.00095	CcSEcCtD
Mitoxantrone—Pain—Docetaxel—melanoma	5.58e-05	0.000942	CcSEcCtD
Mitoxantrone—Constipation—Docetaxel—melanoma	5.58e-05	0.000942	CcSEcCtD
Mitoxantrone—Feeling abnormal—Docetaxel—melanoma	5.38e-05	0.000908	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Docetaxel—melanoma	5.34e-05	0.000901	CcSEcCtD
Mitoxantrone—Body temperature increased—Docetaxel—melanoma	5.16e-05	0.000871	CcSEcCtD
Mitoxantrone—Abdominal pain—Docetaxel—melanoma	5.16e-05	0.000871	CcSEcCtD
Mitoxantrone—ABCB1—head—melanoma	5.16e-05	0.00575	CbGeAlD
Mitoxantrone—Hypersensitivity—Docetaxel—melanoma	4.81e-05	0.000812	CcSEcCtD
Mitoxantrone—Asthenia—Docetaxel—melanoma	4.68e-05	0.00079	CcSEcCtD
Mitoxantrone—Diarrhoea—Docetaxel—melanoma	4.47e-05	0.000754	CcSEcCtD
Mitoxantrone—Vomiting—Docetaxel—melanoma	4.15e-05	0.000701	CcSEcCtD
Mitoxantrone—Rash—Docetaxel—melanoma	4.12e-05	0.000695	CcSEcCtD
Mitoxantrone—Dermatitis—Docetaxel—melanoma	4.11e-05	0.000694	CcSEcCtD
Mitoxantrone—Headache—Docetaxel—melanoma	4.09e-05	0.00069	CcSEcCtD
Mitoxantrone—Nausea—Docetaxel—melanoma	3.88e-05	0.000654	CcSEcCtD
Mitoxantrone—ABCB1—lymph node—melanoma	3.61e-05	0.00402	CbGeAlD
Mitoxantrone—CYP2E1—Metabolism—SDHD—melanoma	6.26e-06	0.000105	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CSPG4—melanoma	6.26e-06	0.000105	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—BSG—melanoma	6.26e-06	0.000105	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle, Mitotic—MAPK1—melanoma	6.25e-06	0.000105	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—IL2—melanoma	6.25e-06	0.000105	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—melanoma	6.22e-06	0.000105	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PLCB4—melanoma	6.22e-06	0.000105	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—CYP17A1—melanoma	6.18e-06	0.000104	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—melanoma	6.14e-06	0.000103	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	6.1e-06	0.000103	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—GPAM—melanoma	6.06e-06	0.000102	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—CTNNB1—melanoma	6.03e-06	0.000102	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—ALB—melanoma	6.02e-06	0.000101	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—melanoma	6e-06	0.000101	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—AKT3—melanoma	5.98e-06	0.000101	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—CYP17A1—melanoma	5.98e-06	0.000101	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ACER3—melanoma	5.95e-06	0.0001	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	5.9e-06	9.93e-05	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—CDKN1A—melanoma	5.89e-06	9.92e-05	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—PTEN—melanoma	5.88e-06	9.9e-05	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—MAPK3—melanoma	5.88e-06	9.9e-05	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—NFKB1—melanoma	5.85e-06	9.85e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—SLC6A11—melanoma	5.85e-06	9.85e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PIP4K2A—melanoma	5.85e-06	9.85e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—GNA11—melanoma	5.84e-06	9.83e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—ALB—melanoma	5.82e-06	9.8e-05	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—AKT1—melanoma	5.82e-06	9.79e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Transmembrane transport of small molecules—ALB—melanoma	5.72e-06	9.64e-05	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—MYC—melanoma	5.72e-06	9.63e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—FASN—melanoma	5.71e-06	9.62e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—SLC5A5—melanoma	5.71e-06	9.61e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—MTAP—melanoma	5.69e-06	9.58e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	5.68e-06	9.57e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—GNA11—melanoma	5.65e-06	9.51e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—SLC5A5—melanoma	5.62e-06	9.46e-05	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—MAPK1—melanoma	5.59e-06	9.42e-05	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—AKT1—melanoma	5.59e-06	9.4e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	5.57e-06	9.38e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—FASN—melanoma	5.53e-06	9.31e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—CYP17A1—melanoma	5.44e-06	9.16e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—UGT2B10—melanoma	5.44e-06	9.16e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—SLC5A5—melanoma	5.44e-06	9.15e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—GNAQ—melanoma	5.43e-06	9.14e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—CD44—melanoma	5.43e-06	9.14e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	5.42e-06	9.13e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	5.37e-06	9.04e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	5.32e-06	8.95e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—ERBB4—melanoma	5.28e-06	8.9e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—melanoma	5.27e-06	8.87e-05	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—STAT3—melanoma	5.26e-06	8.85e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—GNAQ—melanoma	5.25e-06	8.84e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—CD44—melanoma	5.25e-06	8.84e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	5.24e-06	8.83e-05	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—NRAS—melanoma	5.24e-06	8.83e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—CDKN2B—melanoma	5.24e-06	8.82e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	5.23e-06	8.81e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	5.21e-06	8.77e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—CYP1B1—melanoma	5.2e-06	8.76e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PLA2G6—melanoma	5.15e-06	8.68e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	5.14e-06	8.66e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—GNA11—melanoma	5.14e-06	8.65e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—melanoma	5.09e-06	8.58e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PHGDH—melanoma	5.07e-06	8.54e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—LUM—melanoma	5.07e-06	8.54e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—CD86—melanoma	5.07e-06	8.53e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—HS3ST5—melanoma	5.06e-06	8.51e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Transmembrane transport of small molecules—ALB—melanoma	5.04e-06	8.48e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—FASN—melanoma	5.03e-06	8.47e-05	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—MAPK3—melanoma	5.02e-06	8.46e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—HPSE—melanoma	4.97e-06	8.37e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—SLC5A5—melanoma	4.95e-06	8.33e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—FGF1—melanoma	4.91e-06	8.27e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CUBN—melanoma	4.88e-06	8.22e-05	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—MAPK1—melanoma	4.78e-06	8.05e-05	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—EGFR—melanoma	4.78e-06	8.05e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—GNAQ—melanoma	4.78e-06	8.04e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—CD44—melanoma	4.78e-06	8.04e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PDGFRA—melanoma	4.76e-06	8.01e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	4.73e-06	7.96e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CSPG4—melanoma	4.71e-06	7.94e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—BSG—melanoma	4.71e-06	7.94e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—SDHD—melanoma	4.71e-06	7.94e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PRKCA—melanoma	4.71e-06	7.93e-05	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—TP53—melanoma	4.69e-06	7.91e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—ERCC2—melanoma	4.67e-06	7.87e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—VCAN—melanoma	4.63e-06	7.8e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—MAP2K2—melanoma	4.6e-06	7.75e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—PTEN—melanoma	4.59e-06	7.73e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—CYP1B1—melanoma	4.58e-06	7.71e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—GPAM—melanoma	4.56e-06	7.69e-05	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—KRAS—melanoma	4.51e-06	7.6e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	4.47e-06	7.53e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—PTEN—melanoma	4.44e-06	7.48e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—HLA-A—melanoma	4.38e-06	7.37e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—TERT—melanoma	4.38e-06	7.37e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—RAC1—melanoma	4.37e-06	7.35e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—melanoma	4.35e-06	7.32e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—ABCB1—melanoma	4.29e-06	7.22e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	4.25e-06	7.16e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	4.25e-06	7.16e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—HIF1A—melanoma	4.19e-06	7.05e-05	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—PIK3CA—melanoma	4.15e-06	6.98e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—ABCB1—melanoma	4.15e-06	6.98e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—melanoma	4.05e-06	6.82e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	4.02e-06	6.77e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PRKCA—melanoma	3.94e-06	6.64e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—ERCC2—melanoma	3.91e-06	6.59e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CYP17A1—melanoma	3.91e-06	6.58e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PLA2G6—melanoma	3.88e-06	6.54e-05	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—HRAS—melanoma	3.84e-06	6.46e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PLCB4—melanoma	3.83e-06	6.45e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PRKCA—melanoma	3.81e-06	6.42e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—NOS2—melanoma	3.81e-06	6.41e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—ERCC2—melanoma	3.78e-06	6.37e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—NOTCH1—melanoma	3.77e-06	6.35e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—ABCB1—melanoma	3.77e-06	6.35e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—CD80—melanoma	3.7e-06	6.22e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	3.69e-06	6.22e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—KIT—melanoma	3.69e-06	6.21e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—APC—melanoma	3.69e-06	6.21e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—GNA11—melanoma	3.69e-06	6.21e-05	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—IL6—melanoma	3.67e-06	6.18e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—EGF—melanoma	3.65e-06	6.14e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—FASN—melanoma	3.61e-06	6.08e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—SLC6A11—melanoma	3.6e-06	6.07e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PIP4K2A—melanoma	3.6e-06	6.07e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	3.57e-06	6.01e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—SLC5A5—melanoma	3.55e-06	5.98e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—MTAP—melanoma	3.5e-06	5.9e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—VCAN—melanoma	3.49e-06	5.87e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PRKCA—melanoma	3.47e-06	5.84e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—BRAF—melanoma	3.47e-06	5.84e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—ERCC2—melanoma	3.44e-06	5.8e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—GNAQ—melanoma	3.43e-06	5.77e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CD44—melanoma	3.43e-06	5.77e-05	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—AKT1—melanoma	3.39e-06	5.7e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CYP1B1—melanoma	3.29e-06	5.54e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—MAP2K1—melanoma	3.26e-06	5.5e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PIK3CD—melanoma	3.24e-06	5.46e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	3.24e-06	5.46e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	3.13e-06	5.28e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—LUM—melanoma	3.12e-06	5.26e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PHGDH—melanoma	3.12e-06	5.26e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—FGF2—melanoma	3.11e-06	5.23e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PIK3CG—melanoma	3.09e-06	5.2e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—HPSE—melanoma	3.06e-06	5.16e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	3.02e-06	5.08e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CUBN—melanoma	3.01e-06	5.06e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PIK3CG—melanoma	2.99e-06	5.03e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PPARG—melanoma	2.98e-06	5.02e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CYP17A1—melanoma	2.94e-06	4.95e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—MDM2—melanoma	2.91e-06	4.89e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—SDHD—melanoma	2.9e-06	4.89e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—BSG—melanoma	2.9e-06	4.89e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CSPG4—melanoma	2.9e-06	4.89e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PPARG—melanoma	2.88e-06	4.86e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—ERBB2—melanoma	2.86e-06	4.82e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PIK3CB—melanoma	2.83e-06	4.76e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—CD4—melanoma	2.82e-06	4.75e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GPAM—melanoma	2.81e-06	4.74e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PTGS2—melanoma	2.8e-06	4.72e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—GNA11—melanoma	2.78e-06	4.68e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	2.72e-06	4.59e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—FASN—melanoma	2.72e-06	4.58e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PIK3CG—melanoma	2.72e-06	4.58e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PIK3CD—melanoma	2.72e-06	4.57e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—ABCB1—melanoma	2.71e-06	4.56e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—ALB—melanoma	2.68e-06	4.51e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—SLC5A5—melanoma	2.67e-06	4.5e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—CDKN1B—melanoma	2.65e-06	4.47e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PIK3CD—melanoma	2.63e-06	4.42e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PPARG—melanoma	2.62e-06	4.42e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—ALB—melanoma	2.59e-06	4.37e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—GNAQ—melanoma	2.58e-06	4.35e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CD44—melanoma	2.58e-06	4.35e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—CTNNB1—melanoma	2.51e-06	4.22e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PRKCA—melanoma	2.49e-06	4.2e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CYP1B1—melanoma	2.48e-06	4.17e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—ERCC2—melanoma	2.47e-06	4.16e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—CDKN1A—melanoma	2.45e-06	4.12e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PTEN—melanoma	2.44e-06	4.11e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PLA2G6—melanoma	2.39e-06	4.03e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PIK3CD—melanoma	2.39e-06	4.02e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PIK3CB—melanoma	2.37e-06	3.99e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—ALB—melanoma	2.36e-06	3.97e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PTGS2—melanoma	2.35e-06	3.95e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PIK3CB—melanoma	2.29e-06	3.86e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PTGS2—melanoma	2.27e-06	3.82e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—STAT3—melanoma	2.18e-06	3.68e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—NRAS—melanoma	2.18e-06	3.67e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—VCAN—melanoma	2.15e-06	3.62e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—MAPK3—melanoma	2.09e-06	3.51e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PIK3CB—melanoma	2.08e-06	3.51e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PTGS2—melanoma	2.06e-06	3.48e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PTEN—melanoma	2.05e-06	3.44e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—MYC—melanoma	2.03e-06	3.42e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—MAPK1—melanoma	1.99e-06	3.34e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—EGFR—melanoma	1.99e-06	3.34e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PTEN—melanoma	1.98e-06	3.33e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PIK3CG—melanoma	1.95e-06	3.29e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PPARG—melanoma	1.88e-06	3.17e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PRKCA—melanoma	1.88e-06	3.16e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—KRAS—melanoma	1.88e-06	3.16e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—ERCC2—melanoma	1.86e-06	3.13e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CYP17A1—melanoma	1.81e-06	3.05e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PTEN—melanoma	1.8e-06	3.03e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PIK3CA—melanoma	1.72e-06	2.9e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PIK3CD—melanoma	1.72e-06	2.89e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GNA11—melanoma	1.71e-06	2.88e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—ALB—melanoma	1.69e-06	2.85e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—FASN—melanoma	1.67e-06	2.82e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—SLC5A5—melanoma	1.65e-06	2.77e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—HRAS—melanoma	1.59e-06	2.68e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GNAQ—melanoma	1.59e-06	2.68e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CD44—melanoma	1.59e-06	2.68e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—IL6—melanoma	1.53e-06	2.57e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CYP1B1—melanoma	1.53e-06	2.57e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PIK3CB—melanoma	1.5e-06	2.52e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PTGS2—melanoma	1.48e-06	2.5e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PIK3CG—melanoma	1.47e-06	2.47e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PIK3CA—melanoma	1.44e-06	2.43e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PPARG—melanoma	1.42e-06	2.39e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—AKT1—melanoma	1.41e-06	2.37e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PIK3CA—melanoma	1.4e-06	2.35e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PTEN—melanoma	1.29e-06	2.18e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PIK3CD—melanoma	1.29e-06	2.18e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—ALB—melanoma	1.28e-06	2.15e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PIK3CA—melanoma	1.27e-06	2.14e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ABCB1—melanoma	1.26e-06	2.12e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—AKT1—melanoma	1.18e-06	1.99e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PRKCA—melanoma	1.16e-06	1.95e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ERCC2—melanoma	1.15e-06	1.93e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—AKT1—melanoma	1.14e-06	1.92e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PIK3CB—melanoma	1.13e-06	1.9e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PTGS2—melanoma	1.12e-06	1.88e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—AKT1—melanoma	1.04e-06	1.75e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PTEN—melanoma	9.73e-07	1.64e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PIK3CA—melanoma	9.12e-07	1.54e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PIK3CG—melanoma	9.06e-07	1.52e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PPARG—melanoma	8.74e-07	1.47e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PIK3CD—melanoma	7.96e-07	1.34e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ALB—melanoma	7.86e-07	1.32e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—AKT1—melanoma	7.45e-07	1.25e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PIK3CB—melanoma	6.94e-07	1.17e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PTGS2—melanoma	6.88e-07	1.16e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PIK3CA—melanoma	6.87e-07	1.16e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PTEN—melanoma	6e-07	1.01e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—AKT1—melanoma	5.61e-07	9.44e-06	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PIK3CA—melanoma	4.23e-07	7.12e-06	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—AKT1—melanoma	3.46e-07	5.82e-06	CbGpPWpGaD
